ONLINE DATABASE SEARCH -
HIV-LS-369-MEMO
1.
60291 HIV-LS-369;
PUBMED-HIV-3/5/2007
The role of N-glycosylation sites on the CXCR4 receptor for CXCL-12
binding and signaling and X4 HIV-1 viral infectivity
Huskens, D, Princen, K, Schreiber, M, and Schols, D
Virology 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
60292 HIV-LS-369;
PUBMED-HIV-3/5/2007
Resistance Mutations in Subtype C HIV Type 1 Isolates from Indian
Patients of Mumbai Receiving NRTIs Plus NNRTIs and Experiencing a Treatment
Failure: Resistance to AR
Deshpande, A, Jauvin, V, Magnin, N, Pinson, P, Faure, M, Masquelier, B,
Aurillac-Lavignolle, V, and Fleury, HJ
AIDS Res Hum Retroviruses 2007. 23(2): 335-40
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
60293 HIV-LS-369;
SCIFINDER-HIV-2/26/2007
Pyranopyridines and oxepinopyridines as protectants from HIV infection,
their preparation, pharmaceutical compositions, and use in
therapy
Gudmundsson, Kristjan
PATENT: WO
2007008539 ISSUE DATE: 20070118
APPLICATION: 2006 PP:
70pp.
ASSIGNEE: (Smithkline
Beecham Corporation, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
60294 HIV-LS-369;
SCIFINDER-HIV-2/26/2007
Preparation of
1-[2',3'-dideoxy-3'-C-(hydroxymethyl)-b-D-erythropentofuranosyl] cytosine
derivatives as HIV inhibitors
Zhou, Xiao-Xiong and Sahlberg, Christer
PATENT: WO 2007006707
ISSUE DATE: 20070118
APPLICATION: 2006 PP:
81pp.
ASSIGNEE: (Medivir AB,
Swed.
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
60295 HIV-LS-369;
PUBMED-HIV-3/5/2007
Bis-cycloSal-d4T-monophosphates: Drugs That Deliver Two Molecules of
Bioactive Nucleotides
Ducho, C, Gorbig, U, Jessel, S, Gisch, N, Balzarini, J, and Meier,
C
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
60296 HIV-LS-369;
SCIFINDER-HIV-2/26/2007
Non-nucleoside reverse transcriptase inhibitors
Williams, Theresa M and Zhang, Xu-Fang
PATENT: WO
2007021629 ISSUE DATE: 20070222
APPLICATION: 2006
ASSIGNEE: (Merck & Co.,
Inc. USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
7.
60297 HIV-LS-369;
PUBMED-HIV-3/5/2007
Anti HIV-1 virucidal activity of polyamide nucleic acid-membrane
transducing peptide conjugates targeted to primer binding site of HIV-1
genome
Tripathi, S, Chaubey, B, Barton, BE, and Pandey, VN
Virology 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
60298 HIV-LS-369;
PUBMED-HIV-3/5/2007
Synthesis
and anti-HIV-1 activities of novel podophyllotoxin derivatives
Chen, SW, Wang, YH, Jin, Y, Tian, X, Zheng, YT, Luo, DQ, and Tu,
YQ
Bioorg Med Chem Lett 2006.
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
60299 HIV-LS-369;
PUBMED-HIV-3/5/2007
Evidence against a direct antiviral activity of the proteasome during the
early steps of HIV-1 replication
Dueck, M and Guatelli, J
Virology 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
60300 HIV-LS-369;
SCIFINDER-HIV-2/26/2007
Preparation and application of 2-alkylthio-5-alkyl-6-(1-cyanoarylmethyl)
uracil compound as s-dabo reverse transcriptase inhibitor
Chen, Fener and Ji, Lei
PATENT: CN
1903847 ISSUE DATE:
20070131
APPLICATION: 1002-9770 PP:
10pp.
ASSIGNEE: (Fudan University,
Peop. Rep. China
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
60301 HIV-LS-369;
PUBMED-HIV-3/5/2007
Arzanol, an Anti-inflammatory and Anti-HIV-1 Phloroglucinol alpha-Pyrone
from Helichrysum italicum ssp. microphyllum
Appendino, G, Ottino, M, Marquez, N, Bianchi, F, Giana, A, Ballero, M,
Sterner, O, Fiebich, BL, and Munoz, E
J Nat Prod 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
60302 HIV-LS-369;
PUBMED-HIV-3/5/2007
HIV entry inhibition by the envelope 2 glycoprotein of GB virus
C
Jung, S, Eichenmuller, M, Donhauser, N, Neipel, F, Engel, AM, Hess, G,
Fleckenstein, B, and Reil, H
AIDS 2007. 21 (5):
645-7
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
60303 HIV-LS-369;
PUBMED-HIV-3/5/2007
Primary structure and carbohydrate-binding specificity of a potent
anti-HIV lectin isolated from the filamentous cyanobacterium, oscillatoria
agardhii
Sato, Y, Okuyama, S, and Hori, K
J Biol Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
60304 HIV-LS-369;
PUBMED-HIV-3/5/2007
Identification of Nonpeptide CCR5 Receptor Agonists by Structure-based
Virtual Screening
Kellenberger, E, Springael, JY, Parmentier, M, Hachet-Haas, M, Galzi, JL,
and Rognan, D
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
60305 HIV-LS-369;
PUBMED-HIV-3/5/2007
Abacavir sulfate/lamivudine/zidovudine fixed combination in the treatment
of HIV infection
Keiser, P and Nassar, N
Expert Opin Pharmacother 2007. 8(4): 477-83
View Data on the NIAID Therapeutics Website
HYPERLINK:
16.
60306 HIV-LS-369;
PUBMED-HIV-3/5/2007
Direct Inactivation of HIV-1 by a Novel Small Molecule Entry Inhibitor
DCM205
Duong, YT, Meadows, DC, Srivastava, IK, Gervay-Hague, J, and North,
TN
Antimicrob Agents Chemother 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
17.
60307 HIV-LS-369;
SCIFINDER-HIV-2/26/2007
Noninfectious papilloma virus-like particles inhibit HIV-1 replication:
implications for immune control of HIV-1 infection by IL-27
Fakruddin J Mohamad, Lempicki Richard A, Gorelick Robert J, Yang Jun,
Adelsberger Joseph W, Garcia-Pineres Alfonso J, Pinto Ligia A, Lane H Clifford,
and Imamichi Tomozumi
Blood 2007. 109(5):
1841-9.
View Data on the NIAID Therapeutics Website
HYPERLINK:
18.
60308 HIV-LS-369;
SCIFINDER-HIV-2/26/2007
Preparation of analogs and derivatives of prostratin and related phorbol
compounds for use as analgesics
Xu, Rensheng, Zhao, Weimin, and Jiang, Chun
PATENT: WO
2007009055 ISSUE DATE: 20070118
APPLICATION: 2006 PP:
80pp.
ASSIGNEE: (Salvia Sciences,
Inc. USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
19.
60309 HIV-LS-369;
PUBMED-HIV-3/5/2007
A New Benzofuranone and Anti-HIV Constituents from the Stems of Rhus
chinensis
Gu, Q, Wang, RR, Zhang, XM, Wang, YH, Zheng, YT, Zhou, J, and Chen,
JJ
Planta Med 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
20.
60310 HIV-LS-369;
PUBMED-HIV-3/5/2007
Characterization of a replication-competent, integrase-defective human
immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the
discovery and validation of HIV integrase inhibitors
Daelemans, D, Lu, R, De
Clercq, E, and Engelman, A
J Virol 2007 .
View Data on the NIAID Therapeutics Website
HYPERLINK:
21.
60311 HIV-LS-369;
PUBMED-HIV-3/5/2007
Prediction of the binding model of HIV-1 gp41 with small molecule
inhibitors
Jun, Tan J, Kong, R, Xin, Wang C, and Zu, Chen W
Conf Proc IEEE Eng Med Biol Soc 2005. 5: 4755-8
View Data on the NIAID Therapeutics Website
HYPERLINK:
22.
60312 HIV-LS-369;
PUBMED-HIV-3/5/2007
Targeting potential and anti-HIV activity of lamivudine loaded
mannosylated poly (propyleneimine) dendrimer
Dutta, T and Jain, NK
Biochim Biophys Acta 2007.
1770(4): 681-6
View Data on the NIAID Therapeutics Website
HYPERLINK:
23.
60313 HIV-LS-369;
WOS-HIV-2/26/2007
Synthesis of diastereomeric 3-hydroxy-4-pyrrolidinyl derivatives of
nucleobases
Rejman, D, Kocalka, P, Budesinsky, M, Pohl, R, and Rosenberg,
I
TETRAHEDRON 2007.
63(5): 1243-1253, 11
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243742800022
24.
60314 HIV-LS-369;
WOS-HIV-2/26/2007
Binding kinetics, uptake and intracellular accumulation of F105, an
anti-gp 120 human IgG1 kappa monoclonal antibody, in HIV-1 infected
cells
Clayton, R, Ohagen, A,
Goethals, O, Smets, A, Van Loock, M, Michiels, L, Kennedy-Johnston, E,
Cunningham, M, Jiang, HY, Bola, S, Gutshall, L, Gunn, G, Del Vecchio, A,
Sarisky, R, Hallenberger, S, and Hertogs, K
JOURNAL OF VIROLOGICAL METHODS 2007. 139(1): 17-23, 7
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243740100003
25.
60315 HIV-LS-369;
WOS-HIV-3/4/2007
The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary
human macrophages
Stantchev, TS, Markovic, I, Telford, WG, Clouse, KA, and Broder,
CC
VIRUS RESEARCH
2007. 123(2):
178-189, 12
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000244017300009
26.
60316 HIV-LS-369;
WOS-HIV-3/4/2007
Antiviral activity of HIV type 1 protease inhibitors nelfinavir and
indinavir in vivo is not influenced by P-glycoprotein activity on CD4(+) T
cells
Sankatsing, SUC, Cornelissen, M, Kloosterboer, N, Crommentuyn, KML,
Bosch, TM, Mul, FP, Jurriaans, S, Huitema, ADR, Beijnen, JH, Lange, JMA, Prins,
JM, and Schuitemaker, H
AIDS RESEARCH AND HUMAN RETROVIRUSES 2007. 23(1): 19-27, 9
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243995300003
27.
60317 HIV-LS-369;
WOS-HIV-3/4/2007
Inhibition of HIV type 1 replication in CD4(+) and CD14(+) cells purified
from HIV type 1-infected individuals by the 2-5A agonist immunomodulator,
2-5A(N6B)
Dimitrova, DI, Reichenbach, NL, Yang, XW, Pfleiderer, W, Charubala, R,
Gaughan, JP, Suh, B, Henderson, EE, Suhadolnik, RJ, and Rogers,
TJ
AIDS RESEARCH AND HUMAN RETROVIRUSES 2007. 23(1): 123-134, 12
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000243995300017